相关产品推荐更多 >

GARP (LRRC32) Antibody, anti-human, Vio® Bright B515, REAfinity™, 30 tests in 60 µL
询价
CD14 Antibody, anti-mouse, PE-Vio® 770, REAfinity™, 30 µg in 200 µL
询价
TCR Vβ13.1 Antibody, anti-human, APC, REAfinity™, 30 tests in 60 µL
询价
CD21 Antibody, anti-human, APC, REAfinity™, 30 tests in 60 µL
询价
FPRL1/FPR2 Antibody, anti-human, PerCP-Vio® 700, REAfinity™, 30 tests in 60 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
CD267 (TACI)
- 亚型:
recombinant human IgG1
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REA1229
- 标记物:
PE-Vio 670
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry
- 浓度:
1:50
- 抗体英文名:
CD267 (TACI) Antibody, anti-human, REAfinity™
- 抗体名:
CD267 (TACI) Antibody, anti-human, REAfinity™
- 规格:
100 tests in 200 µL
Identification and enumeration of CD267 (TACI)+ cells by flow cytometryClone REA1229 recognizes the human CD267 antigen, a 32 kDa type III transmembrane protein belonging to the TNF receptor superfamily. CD267 as receptor binds to BAFF and APRIL and plays an important role in the stimulation of B- and T-cell function and in the regulation of humoral immunity. CD267 expression is found in CD27+ memory B cells, tonsillar and bone marrow plasma cells, in a subpopulation of activated CD27-, non GC cells and in a small subset of naïve blood and tonsil B cells. CD267 is also expressed on many lymphomas such as multiple myeloma and Hodgkin and non-Hodgkin lymphomas. Mutations in CD267 are often associated with common variable immunodeficiency in humans. Signaling via CD267 leads to activation of the transcription factors NFAT, AP1, and NF-kappa-B. | Additional information: Clone REA1229 displays negligible binding to Fc receptors.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Salzer, U. et al. (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37 (8): 820–828. | Mackay, F. et al. (2008) TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev. 19 (3–4): 263–276.
技术资料暂无技术资料 索取技术资料
文献支持
CD267 (TACI) Antibody, anti-human, PE-Vio® 670, REAfinity™, 100 tests in 200 µL
询价





